These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 29309564)

  • 21. Genotype-Phenotype Correlation of
    Yamagata K; Horie M; Aiba T; Ogawa S; Aizawa Y; Ohe T; Yamagishi M; Makita N; Sakurada H; Tanaka T; Shimizu A; Hagiwara N; Kishi R; Nakano Y; Takagi M; Makiyama T; Ohno S; Fukuda K; Watanabe H; Morita H; Hayashi K; Kusano K; Kamakura S; Yasuda S; Ogawa H; Miyamoto Y; Kapplinger JD; Ackerman MJ; Shimizu W
    Circulation; 2017 Jun; 135(23):2255-2270. PubMed ID: 28341781
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New-onset atrial fibrillation as first clinical manifestation of latent Brugada syndrome: prevalence and clinical significance.
    Pappone C; Radinovic A; Manguso F; Vicedomini G; Sala S; Sacco FM; Ciconte G; Saviano M; Ferrari M; Sommariva E; Sacchi S; Ciaccio C; Kallergis EM; Santinelli V
    Eur Heart J; 2009 Dec; 30(24):2985-92. PubMed ID: 19696190
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Flecainide test in Brugada syndrome: a reproducible but risky tool.
    Gasparini M; Priori SG; Mantica M; Napolitano C; Galimberti P; Ceriotti C; Simonini S
    Pacing Clin Electrophysiol; 2003 Jan; 26(1P2):338-41. PubMed ID: 12687841
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Value of the sodium-channel blocker challenge in Brugada syndrome.
    Therasse D; Sacher F; Babuty D; Mabo P; Mansourati J; Kyndt F; Redon R; Schott JJ; Barc J; Probst V; Gourraud JB
    Int J Cardiol; 2017 Oct; 245():178-180. PubMed ID: 28784436
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Brugada syndrome: clinical presentation and genotype-correlation with magnetic resonance imaging parameters.
    Rudic B; Schimpf R; Veltmann C; Doesch C; Tülümen E; Schoenberg SO; Borggrefe M; Papavassiliu T
    Europace; 2016 Sep; 18(9):1411-9. PubMed ID: 26511399
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Yield and Pitfalls of Ajmaline Testing in the Evaluation of Unexplained Cardiac Arrest and Sudden Unexplained Death: Single-Center Experience With 482 Families.
    Tadros R; Nannenberg EA; Lieve KV; Škorić-Milosavljević D; Lahrouchi N; Lekanne Deprez RH; Vendrik J; Reckman YJ; Postema PG; Amin AS; Bezzina CR; Wilde AAM; Tan HL
    JACC Clin Electrophysiol; 2017 Dec; 3(12):1400-1408. PubMed ID: 29759671
    [TBL] [Abstract][Full Text] [Related]  

  • 27.
    Makarawate P; Chaosuwannakit N; Vannaprasaht S; Sahasthas D; Koo SH; Lee EJD; Tassaneeyakul W; Barajas-Martinez H; Hu D; Sawanyawisuth K
    J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28584071
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparable clinical characteristics in Brugada syndrome patients harboring SCN5A or novel SCN10A variants.
    Monasky MM; Micaglio E; Vicedomini G; Locati ET; Ciconte G; Giannelli L; Giordano F; Crisà S; Vecchi M; Borrelli V; Ghiroldi A; D'Imperio S; Di Resta C; Benedetti S; Ferrari M; Santinelli V; Anastasia L; Pappone C
    Europace; 2019 Oct; 21(10):1550-1558. PubMed ID: 31292628
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lack of genotype-phenotype correlation in Brugada Syndrome and Sudden Arrhythmic Death Syndrome families with reported pathogenic SCN1B variants.
    Gray B; Hasdemir C; Ingles J; Aiba T; Makita N; Probst V; Wilde AAM; Newbury-Ecob R; Sheppard MN; Semsarian C; Sy RW; Behr ER
    Heart Rhythm; 2018 Jul; 15(7):1051-1057. PubMed ID: 29758173
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical characteristics, management, and prognosis of elderly patients with Brugada syndrome.
    Conte G; DE Asmundis C; Sieira J; Levinstein M; Chierchia GB; DI Giovanni G; Baltogiannis G; Ciconte G; Saitoh Y; Casado-Arroyo R; Pappaert G; Brugada P
    J Cardiovasc Electrophysiol; 2014 May; 25(5):514-519. PubMed ID: 24400668
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predicting cardiac electrical response to sodium-channel blockade and Brugada syndrome using polygenic risk scores.
    Tadros R; Tan HL; ; El Mathari S; Kors JA; Postema PG; Lahrouchi N; Beekman L; Radivojkov-Blagojevic M; Amin AS; Meitinger T; Tanck MW; Wilde AA; Bezzina CR
    Eur Heart J; 2019 Oct; 40(37):3097-3107. PubMed ID: 31504448
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of type 1 Brugada ECG pattern after administration of Class 1C drugs in patients with type 1 myotonic dystrophy: Myotonic dystrophy as a part of the Brugada syndrome.
    Maury P; Audoubert M; Cintas P; Rollin A; Duparc A; Mondoly P; Chiriac AM; Acket B; Zhao X; Pasquié JL; Cardin C; Delay M; Sadron M; Carrié D; Galinier M; Davy JM; Arne-Bès MC; Raczka F
    Heart Rhythm; 2014 Oct; 11(10):1721-7. PubMed ID: 25016148
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High prevalence of concealed Brugada syndrome in patients with atrioventricular nodal reentrant tachycardia.
    Hasdemir C; Payzin S; Kocabas U; Sahin H; Yildirim N; Alp A; Aydin M; Pfeiffer R; Burashnikov E; Wu Y; Antzelevitch C
    Heart Rhythm; 2015 Jul; 12(7):1584-94. PubMed ID: 25998140
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gender differences in clinical manifestations of Brugada syndrome.
    Benito B; Sarkozy A; Mont L; Henkens S; Berruezo A; Tamborero D; Arzamendi D; Berne P; Brugada R; Brugada P; Brugada J
    J Am Coll Cardiol; 2008 Nov; 52(19):1567-73. PubMed ID: 19007594
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tpeak-Tend interval and Tpeak-Tend/QT ratio in patients with Brugada syndrome.
    Zumhagen S; Zeidler EM; Stallmeyer B; Ernsting M; Eckardt L; Schulze-Bahr E
    Europace; 2016 Dec; 18(12):1866-1872. PubMed ID: 26941339
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sodium-channel blocker challenge in the familial screening of Brugada syndrome: Safety and predictors of positivity.
    Therasse D; Sacher F; Petit B; Babuty D; Mabo P; Martins R; Jesel L; Maury P; Pasquie JL; Mansourati J; Dupuis JM; Kyndt F; Thollet A; Guyomarch B; Barc J; Schott JJ; Le Marec H; Redon R; Probst V; Gourraud JB
    Heart Rhythm; 2017 Oct; 14(10):1442-1448. PubMed ID: 28666944
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A New Electrocardiographic Marker of Sudden Death in Brugada Syndrome: The S-Wave in Lead I.
    Calò L; Giustetto C; Martino A; Sciarra L; Cerrato N; Marziali M; Rauzino J; Carlino G; de Ruvo E; Guerra F; Rebecchi M; Lanzillo C; Anselmino M; Castro A; Turreni F; Penco M; Volpe M; Capucci A; Gaita F
    J Am Coll Cardiol; 2016 Mar; 67(12):1427-1440. PubMed ID: 27012403
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel SCN10A variants associated with Brugada syndrome.
    Fukuyama M; Ohno S; Makiyama T; Horie M
    Europace; 2016 Jun; 18(6):905-11. PubMed ID: 25842276
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnostic value of flecainide testing in unmasking SCN5A-related Brugada syndrome.
    Meregalli PG; Ruijter JM; Hofman N; Bezzina CR; Wilde AA; Tan HL
    J Cardiovasc Electrophysiol; 2006 Aug; 17(8):857-64. PubMed ID: 16764707
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical characteristics and risk of arrhythmic events in patients younger than 12 years diagnosed with Brugada syndrome.
    Righi D; Porco L; Calvieri C; Tamborrino PP; Di Mambro C; Paglia S; Baban A; Silvetti MS; Gnazzo M; Novelli A; Tozzi AE; Drago F
    Heart Rhythm; 2021 Oct; 18(10):1691-1697. PubMed ID: 34147702
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.